ABO and Alzheimer disease: High molecular weight (HMW) Aβo over 50 kDa have been shown to target synapses more efficiently than low molecular weight (LMW) Aβo (Lacor et al., 2004, 2007) and to be the predominant soluble Aβ species in AD brain (Yang et al., 2017).